Kelcie Longaker Aydin, Member

Kelcie Longaker Aydin is a partner at Gordon Feinblatt LLC who focuses her practice on mergers and acquisitions, private equity transactions, and strategic structuring for health care businesses, medical practices, and founder-led companies. She advises buyers, sellers, operators, and investors on the acquisition, growth, and exit of health care platforms, with particular depth in physician practice roll-ups and MSO-based structures.

She has advised on numerous acquisitions, divestitures, and platform-building transactions, including a substantial number of deals in the $50 million to $100 million range. Her experience spans representation of buyers, sellers, and management teams, and she frequently serves as lead deal counsel in transactions involving medical practices and health care services businesses.

Kelcie has significant experience in private equity-style transactions and sponsor-backed growth strategies, including platform and add-on acquisitions. She routinely advises on equity structuring, distribution waterfalls, and investor alignment, and has guided clients through transactions involving multi-owner structures and layered capitalization.

A substantial portion of her practice is devoted to health care M&A and platform development, where she advises on the consolidation and scaling of physician practices and provider-based businesses. She has helped structure multiple MSO-PC and MSO-PLLC arrangements, addressing corporate practice of medicine requirements, management services agreements, and the allocation of enterprise value between clinical and non-clinical entities. Her work often involves designing structures that concentrate enterprise value at the MSO level while maintaining regulatory compliance.

Kelcie also has experience advising on enterprise value creation and exit-readiness, including governance and ownership structures designed to support future recapitalization or sale. She regularly works with lenders, investors, accountants, and other advisors to ensure transaction structures are both commercially viable and regulatorily sound.

Kelcie is the Chair of Gordon Feinblatt’s EMERGE program for start-ups and entrepreneurs, where she leads the firm’s representation of early-stage and growth-stage companies. In this role, she advises founders—many in health care and professional services—on entity formation, capital structuring, and growth strategies designed to position businesses for investment or acquisition.

Her work with emerging companies provides a unique perspective in her M&A practice, allowing her to guide clients from formation through acquisition or exit, often advising on structural decisions years before a transaction occurs.

In connection with her transactional work, Kelcie also advises clients on corporate governance, entity structuring, and licensing considerations, particularly in regulated industries such as health care. She drafts and negotiates operating agreements, investor governance provisions, and multi-entity structures aligned with institutional investment and long-term growth.

She is known for combining transactional execution experience with practical business judgment, helping clients not only close deals, but structure them in a way that supports scalability, operational clarity, and long-term value.

Before joining Gordon Feinblatt, Kelcie practiced at both national and regional law firms, where she was a member of corporate, mergers and acquisitions, and health care teams. She currently serves on the Board of the American Red Cross National Capital & Greater Chesapeake Region, reflecting her continued engagement in community and leadership initiatives.

Private Equity and Health Care Transactions

• Mergers and acquisitions of medical practices and health care services businesses
• Physician practice roll-ups and platform consolidation strategies
• Private equity and sponsor-backed transactions
• Rollover equity, governance, and distribution structures
• Asset and stock purchase agreements and related transaction documents

Health Care Structuring and Compliance

• MSO-PC and MSO-PLLC structures
• Corporate practice of medicine considerations
• Allocation of clinical and non-clinical assets
• Management services agreements

Corporate and Growth Advisory

• Founder and investor governance arrangements
• Entity structuring and capitalization
• Operating agreements, bylaws, and multi-entity platforms
• Exit planning and investment readiness

Startups and Emerging Companies

• Chair, EMERGE program (startup and growth company representation)
• Entity formation and early-stage structuring
• Commercial agreements and scaling strategies